All Stories

  1. Dialysis Recovery Time—Can We Do Better?

    Article • Kidney360, September 2024, Wolters Kluwer Health

    Prof Peter G Kerr

  2. Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study

    Article • Nephrology, September 2017, Wiley

    Prof Peter G Kerr, Professor Trevor A Mori

  3. Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL

    Article • Journal of Diabetes and its Complications, February 2017, Elsevier

    Prof Peter G Kerr

  4. The effect of holiday haemodialysis treatments on patient mood, adverse symptoms and subjective wellbeing using the Big Red Kidney Bus

    Article • Nephrology, January 2017, Wiley

    Prof Peter G Kerr

  5. Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease

    Article • PLoS ONE, December 2016, PLOS

    Prof Peter G Kerr

  6. Reliability and validity of the coping strategy inventory-short form applied to hemodialysis patients in 13 countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

    Article • Journal of Psychosomatic Research, December 2016, Elsevier

    Dr Hugh C Rayner, Prof Peter G Kerr

  7. Conservative care in ESRD

    Article • Clinical Journal of the American Society of Nephrology, October 2016, American Society of Nephrology

    Michael J Germain, Prof Peter G Kerr, Professor Rachael L Morton

  8. Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study

    Article • EBioMedicine, October 2016, Elsevier

    Prof Peter G Kerr

  9. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study

    Article • American Journal of Kidney Diseases, September 2016, Elsevier

    Prof Peter G Kerr

  10. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices

    Article • The Lancet, July 2016, Elsevier

    Prof Peter G Kerr

  11. Primary and tertiary health professionals’ views on the health-care of patients with co-morbid diabetes and chronic kidney disease – a qualitative study

    Article • BMC Nephrology, May 2016, Springer Science + Business Media

    Prof Peter G Kerr

  12. Keeping Home Dialysis Patients at Home

    Article • American Journal of Kidney Diseases, April 2016, Elsevier

    Prof Peter G Kerr

  13. Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuria

    Article • Bone, April 2016, Elsevier

    Prof Peter G Kerr

  14. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations

    Article • American Journal of Kidney Diseases, April 2016, Elsevier

    Prof Peter G Kerr

  15. How much is enough? An investigation of the relationship between haemodialysis adequacy and quality of life of elderly patients

    Article • Nephrology, March 2016, Wiley

    Mr EDWARD ZIMBUDZI, Prof Peter G Kerr, Sophia Zoungas

  16. Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal disease

    Article • Regenerative Medicine, March 2016, Future Medicine

    Prof Peter G Kerr

  17. Human podocyte depletion in association with older age and hypertension

    Article • AJP Renal Physiology, January 2016, American Physiological Society

    Prof Peter G Kerr

  18. The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study

    Article • PLoS ONE, January 2016, PLOS

    Prof Peter G Kerr

  19. Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population

    Article • American Journal of Kidney Diseases, September 2015, Elsevier

    Professor John W. M. Agar, Prof Peter G Kerr

  20. Standardised outcomes in nephrology – Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis

    Article • Trials, August 2015, Springer Science + Business Media

    Prof Peter G Kerr

  21. Research Priorities in CKD: Report of a National Workshop Conducted in Australia

    Article • American Journal of Kidney Diseases, August 2015, Elsevier

    Prof Peter G Kerr

  22. Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident Cells

    Article • Journal of the American Society of Nephrology, January 2015, American Society of Nephrology

    Prof Peter G Kerr

  23. Thalassemia Bone Disease: A 19-Year Longitudinal Analysis

    Article • Journal of Bone and Mineral Research, October 2014, Wiley

    Prof Peter G Kerr

  24. High rates of death and hospitalization follow bone fracture among hemodialysis patients

    Article • Kidney International, January 2014, Elsevier

    Prof Peter G Kerr

  25. Editorial

    Article • Nephrology, December 2010, Wiley

    Prof Peter G Kerr

  26. Review: Membranes for haemodialysis

    Article • Nephrology, March 2010, Wiley

    Prof Peter G Kerr

  27. Introduction

    Article • Nephrology, November 2009, Wiley

    Prof Peter G Kerr

  28. Handbook of Dialysis Therapy

    Article • Nephrology, April 2008, Wiley

    Prof Peter G Kerr

  29. ARTERIAL CALCIFICATION AND STIFFNESS IN CHRONIC KIDNEY DISEASE

    Article • Clinical and Experimental Pharmacology and Physiology, July 2007, Wiley

    Prof Peter G Kerr

  30. High-flux dialysers*

    Article • Nephrology, February 2002, Wiley

    Prof Peter G Kerr

  31. ASSESSMENT OF PLATELET FUNCTION IN HAEMODIALYSIS PATIENTS

    Article • Nephrology, February 2002, Wiley

    Prof Peter G Kerr

  32. NOVEL ERYTHROPOIESIS STIMULATING PROTEIN (NESP) MAINTAINS HAEMOGLOBIN IN ESRD PATIENTS WHEN ADMINISTERED ONCE WEEKLY OR ONCE EVERY OTHER WEEK

    Article • Nephrology, October 2000, Wiley

    Prof Peter G Kerr

  33. Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cells

    Article • Immunology and Cell Biology, June 1991, Nature

    Prof Peter G Kerr